With our strong development and regulatory capabilities, and backed by manufacturing sites, that have over 35 regulatory body accreditations, we actively assist customers with Life Cycle management of their products. We assist our customers with:
- Improve / Manage the margins of life cycle products.
- Extent patent life by developing extensions of the current dosage forms :
- Paediatric Dosages
- Modified Release
- Simpler dosage form : Liquid from a Lyophilised form
- Improve supply chain modalities
- Improve operational efficiency
- Site Transfers
- API Source change /Additions
- Regulatory Support
Speak to our
- Pharmaceutical Development Services
- New Dosage form development for existing dosages
- Modified release profiles for existing IR solid dosage form
- Site Transfers: Support on Change of manufacturing sites in APIs / Formulations which needs high levels of project management services, process improvement acumen and strong focus on operational efficiencies
- API Source change / Additions: API source additions for smoothers supply chain and cost reduction
- Regulatory support
High Potency APIs (HPAPIs)
Finished Dosage Manufacturing
Late Lifecycle Management
We manufacture and supply Active Pharmaceutical Ingredients (APIs) through our sites in North America, Europe, and Asia.
Piramal Pharma Solutions now offers High Potency API (HPAPI) services following its acquisition of Ash Stevens, a global leader with over five decades of experience in HPAPI development and cGMP manufacture.
We manufacture, supply and distribute commercial formulations from our facilities in UK and India for Oral Solids and Lexington, USA for Sterile Injectables.